Advances in cancer immunotherapy 2019 – latest trends

Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety of hematological and solid malignancies. The two main drivers behind this success are checkpoint inhibitors (CPIs) and chimeric antigen receptor (CAR) T cells. This review...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruger, Stephan, Ilmer, Matthias, Kobold, Sebastian, Cadilha, Bruno L., Endres, Stefan, Ormanns, Steffen, Schuebbe, Gesa, Renz, Bernhard W., D’Haese, Jan G., Schloesser, Hans, Heinemann, Volker, Subklewe, Marion, Boeck, Stefan, Werner, Jens, von Bergwelt-Baildon, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585101/
https://www.ncbi.nlm.nih.gov/pubmed/31217020
http://dx.doi.org/10.1186/s13046-019-1266-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585101/
https://www.ncbi.nlm.nih.gov/pubmed/31217020
http://dx.doi.org/10.1186/s13046-019-1266-0

Ejemplares similares